Vaccines in Sub-Saharan African Country (Essay Sample)

Vaccines in Sub-Saharan African Country
Student’s First Name, Middle Name, Last Name
Institution Affiliation
Course Code and Number
Instructor’s Name
Assignment Due Date
Vaccines in Sub-Saharan African Country
Humans have been affected by different kind of diseases that has also increased the mortality rate. However, some of these diseases can be prevented or cured. With the development of vaccines, millions of lives have been saved and the spread of diseases are controlled. In Sub-Saharan Africa countries nutritional, communicable, newborn and maternal diseases still dominate (Yaya, Reddy & Pingray, 2020). Vaccines developed that have helped prevent most common diseases in Sub-Sahara Africa are discussed below.
Regeneron (REGN-EB3) and mAb114 antiviral drugs are used in the treatment of Ebola ("Treatment | Ebola (Ebola Virus Disease) | CDC", 2020). Ebola Virus disease is a deadly disease that affects people as well as primates and is mainly found in Sub-Saharan Africa. It spreads through direct contact with an infected person’s body fluids, objects and infected primates. REGN-EB3 was invented by Regeneron pharmaceuticals. After conducting various tests, it was confirmed that the REGN-EB3 vaccine was more effective and reduced the death rates of people infected with Ebola compared to mAb114 and ZMapp. For the creation of the vaccine’s antibodies, Regeneron’s novel, VelociSuite technologies and VelocImmune platform were used (Town, 2019). REGN-EB3 and mAb114 are still being used on the Ebola patients.
Malaria has affected many people in the world, especially Africa. It caused by the Plasmodium parasite carried by an infected female mosquito. Once released into the bloodstream through a mosquito bite, it infects the red blood cells (Burke, 2019). The RTS,S is a candidate vaccine developed by GlaxoSmithKline Biologicals’ (GSKBio). The vaccine is in phase III testing and has proven t